These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 24246093)

  • 1. Mechanism of the anti-platelet effect of natural bioactive compounds: role of peroxisome proliferator-activated receptors activation.
    Fuentes E; Fuentes F; Palomo I
    Platelets; 2014; 25(7):471-9. PubMed ID: 24246093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of antiplatelet action of hypolipidemic, antidiabetic and antihypertensive drugs by PPAR activation: PPAR agonists: new antiplatelet agents.
    Fuentes E; Palomo I
    Vascul Pharmacol; 2014 Sep; 62(3):162-6. PubMed ID: 24874279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of antiplatelet activity of nifedipine: role of peroxisome proliferator-activated receptor-β-γ-dependent processes.
    Shih CY; Lin MH; Fan HC; Chen FC; Chou TC
    J Hypertens; 2014 Jan; 32(1):181-92. PubMed ID: 24126710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory mechanisms of cAMP levels as a multiple target for antiplatelet activity and less bleeding risk.
    Fuentes E; Palomo I
    Thromb Res; 2014 Aug; 134(2):221-6. PubMed ID: 24830902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of peroxisome proliferator-activated receptor γ in simvastatin antiplatelet activity: influences on cAMP and mitogen-activated protein kinases.
    Du H; Hu H; Zheng H; Hao J; Yang J; Cui W
    Thromb Res; 2014 Jul; 134(1):111-20. PubMed ID: 24856644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of α-lipoic acid on platelet aggregation is mediated by PPARs.
    Chou TC; Shih CY; Chen YT
    J Agric Food Chem; 2011 Apr; 59(7):3050-9. PubMed ID: 21391669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet activity of Phellinus baummii methanol extract is mediated by cyclic AMP elevation and inhibition of collagen-activated integrin-α(IIb) β₃ and MAP kinase.
    Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim TH; Lee IK; Cho JY; Park HJ; Kim SK; Yun BS; Rhee MH
    Phytother Res; 2011 Nov; 25(11):1596-603. PubMed ID: 21394810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.
    Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
    Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyridoxine increases nitric oxide biosynthesis in human platelets.
    Wu Y; Liu Y; Han Y; Cui B; Mi Q; Huang Y; Wang L; Jiang Q; Chen Q; Liu N; Ferro A; Ji Y
    Int J Vitam Nutr Res; 2009 Mar; 79(2):95-103. PubMed ID: 20108211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective activation of the prostaglandin E2 receptor subtype EP2 or EP4 leads to inhibition of platelet aggregation.
    Kuriyama S; Kashiwagi H; Yuhki K; Kojima F; Yamada T; Fujino T; Hara A; Takayama K; Maruyama T; Yoshida A; Narumiya S; Ushikubi F
    Thromb Haemost; 2010 Oct; 104(4):796-803. PubMed ID: 20664890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of platelet aggregation by chlorogenic acid via cAMP and cGMP-dependent manner.
    Cho HJ; Kang HJ; Kim YJ; Lee DH; Kwon HW; Kim YY; Park HJ
    Blood Coagul Fibrinolysis; 2012 Oct; 23(7):629-35. PubMed ID: 22885765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
    Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
    Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARbeta/delta agonists modulate platelet function via a mechanism involving PPAR receptors and specific association/repression of PKCalpha--brief report.
    Ali FY; Hall MG; Desvergne B; Warner TD; Mitchell JA
    Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1871-3. PubMed ID: 19696401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2Y₁₂ and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMP.
    Iyú D; Glenn JR; White AE; Fox SC; Dovlatova N; Heptinstall S
    Platelets; 2011; 22(7):504-15. PubMed ID: 21591981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion.
    Hornby EJ; Foster MR; McCabe PJ; Stratton LE
    Thromb Haemost; 1989 Jun; 61(3):429-36. PubMed ID: 2529661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
    Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
    Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ca(2+) /calmodulin-dependent kinase kinase β-AMP-activated protein kinase-α1 pathway regulates phosphorylation of cytoskeletal targets in thrombin-stimulated human platelets.
    Onselaer MB; Oury C; Hunter RW; Eeckhoudt S; Barile N; Lecut C; Morel N; Viollet B; Jacquet LM; Bertrand L; Sakamoto K; Vanoverschelde JL; Beauloye C; Horman S
    J Thromb Haemost; 2014 Jun; 12(6):973-86. PubMed ID: 24655923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine diphosphate receptors on blood platelets: potential new targets for antiplatelet therapy.
    Rozalski M; Nocun M; Watala C
    Acta Biochim Pol; 2005; 52(2):411-5. PubMed ID: 15912207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of anti-platelet activity of davallialactone: involvement of intracellular calcium ions, extracellular signal-regulated kinase 2 and p38 mitogen-activated protein kinase.
    Kim SD; Lee IK; Lee WM; Cho JY; Park HJ; Oh JW; Park SC; Kim SK; Kwak YS; Yun BS; Rhee MH
    Eur J Pharmacol; 2008 Apr; 584(2-3):361-7. PubMed ID: 18313047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.